✦ LIBER ✦

The lymphokine-activated killer cell phenomenon: In vitro and in vivo studies

✍ Scribed by E.A. Grimm; E. Gorelik; M.M. Rosenstein; S.A. Rosenberg

Book ID: 113132431
Publisher: Elsevier Science
Year: 1982
Tongue: English
Weight: 82 KB
Volume: 70
Category: Article
ISSN: 0008-8749
DOI: 10.1016/0008-8749(82)90427-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vitro and in vivo activity of murine

In vitro and in vivo activity of murine lymphokine-activated killer cells after cryopreservation

✍ I. G.H. Schmidt-Wolf; M. Aihara; R. S. Negrin; K. G. Blume; N. J. Chao 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 409 KB

Lymphokine-Activated Killer (LAK) Cell P

Lymphokine-Activated Killer (LAK) Cell Phenomenon in Cluster Headache. “In Vitro” Activation by Recombinant Interleukin-2

✍ M. Giacovazzo; G. Stirparo; L. DeStefano; R Martelletti; C. Rinaldi-Garaci 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

Lymphokine-activated killer cells: analy

Lymphokine-activated killer cells: analysis of their anti-tumour efficacy in vitro and in vivo

✍ Hiserodt, J.C.; Chambers, W.H.; Herberman, R.B. 📂 Article 📅 1988 🏛 Elsevier Science ⚖ 612 KB

Lymphokine-activated killer-cell traffic

Lymphokine-activated killer-cell traffic in metastatic melanoma

✍ Dummer, R; Schäfer, E; Eilles, C; Börner, W; Burg, G 📂 Article 📅 1991 🏛 The Lancet 🌐 English ⚖ 377 KB

Cytokine regulation of cell-to-cell inte

Cytokine regulation of cell-to-cell interactions in lymphokine-activated killer cell cytotoxicity in vitro

✍ Toshiyuki Takahashi; Hiroshi Ishikura; Kazuhiro Iwai; Chisa Takahashi; Hiroyuki 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 708 KB

Apheresis techniques in lymphokine-activ

Apheresis techniques in lymphokine-activated killer cell production

✍ Irena Sniecinski; Kim Sentinella; Kim Margolin; Bonnie Mills 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 385 KB

Adoptive transfer of autologous lymphokine-activated killer cells (LAK) in conjunction with recombinant interleukin-2 (rIL-2) has been reported to produce significant regression in metastatic disease in patients with advanced cancer. In an effort to confirm the results reported by the Surgery Branch